Updating the natural history of hpv and anogenital cancer
Updating the natural history of hpv and anogenital cancer - yvonne suhor dating
In the Human Papillomavirus (HPV) Immunisation Programme, equity has continued to be achieved for young Māori and Pacific women, and 12 district health boards achieved or exceeded the 2016 HPV immunisation coverage target of 65 percent of 12‑year-old girls having received all three HPV doses.At a population level, the effects of increasing immunisation coverage are clearly discernible, with fewer cases of vaccine-preventable diseases as coverage increases.
I trust this edition, like its predecessors, will prove a valuable resource for health professionals. The information contained within the Handbook was correct at the time of publication.
No person proposing to administer a vaccine to any other person should rely on the advice given in this publication without ﬁrst exercising his or her professional judgement as to the appropriateness of administering that vaccine to another person. This work is licensed under the Creative Commons Attribution 4.0 International licence.
Comments on this book and suggestions for future editions are invited, to enhance the usefulness of future editions. In essence, you are free to: share ie, copy and redistribute the material in any medium or format; adapt ie, remix, transform and build upon the material.
This provides more opportunities for people to be vaccinated against these infectious diseases.
Immunisation is an important opportunity for health professionals to interact with people from all walks of life: mothers with newborns, school-age children, and adults either working or retired. Information on New Zealand epidemiology is sourced from data collated by the Institute of Environmental Science and Research (ESR), on behalf of the Ministry of Health, or from Analytical Services, Ministry of Health.
From July 2017 varicella vaccine will be introduced to the National Immunisation Schedule and is expected to significantly reduce the burden of varicella disease, particularly in young infants.
Immunisation coverage has continued to improve and as at 31 December 2016, 93.3 percent of 8-month-olds and 93.1 percent of 2-year-olds were fully immunised for the quarter.Significant progress has been made for immunisation at age 5 years in recent years, with coverage increasing from 82 percent in June 2015 to 89 percent in December 2016.Gains have consistently been made for Māori infants and children, with an increase in coverage at age 8 months from 78 percent in 2012 to 91 percent in December 2016.These should be sent to the Manager Immunisation, Ministry of Health, at the address below. You must give appropriate credit, provide a link to the licence and indicate if changes were made.Websites Funded vaccines for special groups List of tables List of figures With the publication of the Immunisation Handbook 2017 (the Handbook), it is once again appropriate to extend the Ministry of Health’s thanks to everyone involved in supporting, promoting or delivering immunisations to the people of New Zealand.Both of these editions were updated with a few amendments and PHARMAC’s revised eligibility criteria for some of the vaccines for individuals at increased risk of the relevant vaccine-preventable diseases.